Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
Switzerland
/
Healthcare
Create a narrative
Medacta Group Community
SWX:MOVE Community
1
Narratives
written by author
0
Comments
on narratives written by author
1
Fair Values set
on narratives written by author
Create a narrative
Medacta Group
Popular
Undervalued
Overvalued
Community Investing Ideas
Medacta Group
AN
AnalystConsensusTarget
Consensus Narrative from 7 Analysts
New Geographic Regions And Acquisitions Will Expand Medical Reach
Key Takeaways Geographic and strategic acquisitions promise revenue growth through enhanced market penetration and operational capabilities, especially in sports medicine. Innovative product rollouts and medical education investments are expected to drive revenue by capturing market share and increasing solution adoption.
View narrative
CHF 146.27
FV
14.5% undervalued
intrinsic discount
13.24%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
1
users have followed this narrative
3 days ago
author updated this narrative
Your Valuation for
MOVE
MOVE
Medacta Group
Your Fair Value
CHF
Current Price
CHF 125.00
27.3% undervalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
0
1b
2015
2018
2021
2024
2025
2027
2030
Revenue €1.0b
Earnings €125.0m
Advanced
Set Fair Value